Submitted by aml95 on Thu, 22/05/2025 - 08:46
The Academy of Medical Sciences (AMS) has announced its newly elected biomedical and health scientists to its prestigious Fellowship, and we are delighted that Professor Frank Reimann from the IMS-MRL is included in the list of 54 exceptional researchers.
Frank is Professor of Endocrine Signalling and his research lab, in collaboration with Professor Fiona Gribble, focuses on gut hormones and how they control appetite and insulin release.
The new Fellows have been recognised for their remarkable contributions to advancing medical science, groundbreaking research discoveries and translating developments into benefits for patients and the wider public. Their work exemplifies the Academy’s mission to create an open and progressive research sector that improves health for everyone. The expertise of Fellows elected spans a wide range of clinical and non-clinical disciplines, from infectious disease and stem cell biology to veterinary medicine and dementia research. They join an esteemed Fellowship of 1,450 researchers who are at the heart of the Academy’s work, which includes nurturing the next generation of scientists and shaping research and health policy in the UK and worldwide.
Professor Reimann said:
"I feel very honoured to be recognised for the work of many former and current members of the laboratory. Over the last 20 years, research into the gut brain axis has given rise to new medications now widely used in the treatment of diabetes and obesity and we hope that our work on the physiology of gut hormones will open further therapeutic avenues. I look forward to working with other fellows at the Academy, not least to encourage the next generation to pursue careers in science regardless of their background."
Professor Andrew Morris CBE FRSE PMedSci, President of the Academy of Medical Sciences, said:
“It is a privilege to welcome these 54 exceptional scientists to our Fellowship. Each new Fellow brings unique expertise and perspective to addressing the most significant health challenges facing society. The breadth of disciplines represented in this year’s cohort – from mental health and infectious disease to cancer biology and respiratory medicine – reflects the rich diversity of medical science today. Their election comes at a crucial time when scientific excellence and collaboration across disciplines are essential for addressing global health challenges both now and in the future. We look forward to working with them to advance biomedical research and create an environment where the best science can flourish for the benefit of people everywhere.”
We were also pleased to see that Professor Robert Semple (University of Edinburgh) has also been elected for his work in translational molecular medicine. Professor Semple spent much of his early research career at Cambridge at the IMS-MRL until he moved to Edinburgh in 2017. His research focuses on rare and severe hormonal and metabolic disorders caused by changes in single genes. Professor Claudia Langenberg (Queen Mary, University of London), who until 2022 was a Programme Leader at the MRC Epidemiology Unit here in Cambridge, is also one of the 54 new Fellows.
